Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort

BACKGROUND: It is now well recognised that the risk of severe COVID-19 increases with some long-term conditions (LTCs). However, prior research primarily focuses on individual LTCs and there is a lack of data on the influence of multimorbidity (≥2 LTCs) on the risk of COVID-19. Given the high preval...

Descripción completa

Detalles Bibliográficos
Autores principales: McQueenie, Ross, Foster, Hamish M. E., Jani, Bhautesh D., Katikireddi, Srinivasa Vittal, Sattar, Naveed, Pell, Jill P., Ho, Frederick K., Niedzwiedz, Claire L., Hastie, Claire E., Anderson, Jana, Mark, Patrick B., Sullivan, Michael, O’Donnell, Catherine A., Mair, Frances S., Nicholl, Barbara I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440632/
https://www.ncbi.nlm.nih.gov/pubmed/32817712
http://dx.doi.org/10.1371/journal.pone.0238091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440632/
https://www.ncbi.nlm.nih.gov/pubmed/32817712
http://dx.doi.org/10.1371/journal.pone.0238091

Ejemplares similares